Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages

  Gambineri, Alessandra ^a   Tomassoni, Federica ^a   Gasparini, Daniela Ibarra ^a   Di Rocco, Antonio ^a   Mantovani, Vilma ^a   Pagotto, Uberto ^a   Altieri, Paola ^a   Sanna, Stefania ^b   Fulghesu, Anna Maria ^b   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LUTEINIZING HORMONE; METFORMIN; ORGANIC CATION TRANSPORTER 1; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ALLELE; ANDROSTENEDIONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG METABOLISM; DRUG RESPONSE; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

EID: 77956412409     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0145     Document Type: Article

References (20)

1. Palomba S, Falbo A, Zullo F, Orio Jr F 2009 Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 30:1-50
2. Pasquali R, Gambineri A 2006 Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154:763-775 (Pubitemid 43997712)
3. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, Kroetz DL, Ferrin TE, Clark AG, Risch N, Herskowitz I, Giacomini KM; Pharmacogenetics of Membrane Transporters Investigators 2003 Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 100:5896-5901
4. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Ewens KG, Spielman RS, Leppert PC, Myers ER; for the Reproductive Medicine Network 2008 Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J Clin Endocrinol Metab 93:792-800
5. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y 2002 Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 302: 510-515 (Pubitemid 34787213)
6. Dresser MJ, Leabman MK, Giacomini KM 2001 Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 90:397-421
7. Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM2007 Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117:1422-1431
8. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM; Pharmacogenetics of Membrane Transporters Investigators 2003 Evolutionary conservation predicts function of variants of thehumanorganic cation transporter, OCT1. Proc Natl Acad Sci USA 100:5902-5907
9. Kerb R, Brinkmann U, Chatskaia N, Gorbunov D, Gorboulev V, Mornhinweg E, Keil A, Eichelbaum M, Koepsell H 2002 Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 12: 591-595
10. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, Sheardown SA, Yue L, Burchard EG, Brett CM, Giacomini KM 2008 Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 83:273-280
11. Nies AT, Koepsell H, Winter S, Burk O, Klein K, Kerb R, Zanger UM, Keppler D, Schwab M, Schaeffeler E 2009 Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227-1240
12. Rotterdam ESHRE/ASMR-Sponsored PCOS Consensus Workshop Group 2004 Revised 2004 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19:41-47
13. Ye S, Dhillon S, Ke X, Collins AR, Day IN 2001 An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29:E88
14. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM 2000 Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767-2774
15. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
17. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD 2001 Repeatability characteristics of simple indices of insulin resistance: implication for research application. J Clin Endocrinol Metab 86:5457-5464 (Pubitemid 33070275)
18. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
19. Nestler JE 2008 Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 358:47-54
20. Attia GR, Rainey WE, Carr BR 2001 Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 76:517-524 (Pubitemid 32776545)